Affordable Access

Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.

Authors
  • Connolly, Stuart J
  • Schnell, Daniel J
  • Page, Richard L
  • Wilkinson, William E
  • Marcello, Stephen R
  • Pritchett, Edward L C
Type
Published Article
Journal
American Heart Journal
Publisher
Elsevier
Publication Date
Sep 01, 2003
Volume
146
Issue
3
Pages
489–493
Identifiers
PMID: 12947368
Source
Medline
License
Unknown

Abstract

Azimilide (125 mg/day) reduces the number of symptoms reported at the time of AF recurrence.

Report this publication

Statistics

Seen <100 times